- Home
- MIRA vs FCO Comparison
MIRA vs FCO Comparison
Compare MIRA & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIRA | FCO |
|---|---|---|
| Founded | 2020 | 1991 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.7M | 39.4M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | MIRA | FCO |
|---|---|---|
| Price | $1.50 | $2.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 251.1K | 100.1K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.73 | $4.73 |
| 52 Week High | $2.45 | $6.63 |
Technical Indicators
Market Signals| Indicator | MIRA | FCO |
|---|---|---|
| Relative Strength Index (RSI) | 50.32 | 46.05 |
| Support Level | $1.52 | $2.80 |
| Resistance Level | $1.69 | $3.05 |
| Average True Range (ATR) | 0.08 | 0.08 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 24.00 | 36.00 |
Price Performance
Historical ComparisonAbout MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.